Ageing and Dementia: Journal of Neural Transmission. Supplementa, cartea 53
Editat de Kurt Jellinger, Franz Fazekas, Manfred Windischen Limba Engleză Paperback – 13 iul 1998
Din seria Journal of Neural Transmission. Supplementa
- 5%
Preț: 1191.66 lei - 5%
Preț: 427.76 lei -
Preț: 392.97 lei - 5%
Preț: 362.95 lei - 5%
Preț: 716.11 lei - 5%
Preț: 354.31 lei -
Preț: 367.42 lei - 5%
Preț: 379.89 lei -
Preț: 382.72 lei - 15%
Preț: 671.24 lei - 5%
Preț: 1123.44 lei - 5%
Preț: 1050.57 lei - 5%
Preț: 357.58 lei - 5%
Preț: 376.83 lei -
Preț: 394.29 lei - 15%
Preț: 646.80 lei -
Preț: 383.92 lei - 5%
Preț: 399.23 lei - 5%
Preț: 371.92 lei -
Preț: 382.85 lei - 5%
Preț: 382.95 lei - 5%
Preț: 366.66 lei - 5%
Preț: 376.07 lei - 5%
Preț: 375.35 lei - 5%
Preț: 391.40 lei - 5%
Preț: 1551.42 lei - 5%
Preț: 386.09 lei - 5%
Preț: 370.02 lei - 5%
Preț: 694.25 lei - 5%
Preț: 793.86 lei - 18%
Preț: 1402.03 lei - 5%
Preț: 1369.44 lei - 5%
Preț: 1073.37 lei - 5%
Preț: 1373.11 lei - 5%
Preț: 1053.20 lei - 5%
Preț: 686.90 lei - 5%
Preț: 1061.10 lei - 5%
Preț: 1106.70 lei - 5%
Preț: 1154.10 lei - 5%
Preț: 740.77 lei - 5%
Preț: 1569.73 lei - 5%
Preț: 1479.70 lei - 5%
Preț: 2240.93 lei
Preț: 1377.14 lei
Preț vechi: 1449.63 lei
-5%
Puncte Express: 2066
Carte tipărită la comandă
Livrare economică 08-22 decembrie
Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Specificații
ISBN-13: 9783211831144
ISBN-10: 3211831142
Pagini: 416
Ilustrații: VIII, 407 p.
Dimensiuni: 210 x 297 x 22 mm
Greutate: 0.99 kg
Ediția:Softcover reprint of the original 1st ed. 1998
Editura: SPRINGER VIENNA
Colecția Springer
Seria Journal of Neural Transmission. Supplementa
Locul publicării:Vienna, Austria
ISBN-10: 3211831142
Pagini: 416
Ilustrații: VIII, 407 p.
Dimensiuni: 210 x 297 x 22 mm
Greutate: 0.99 kg
Ediția:Softcover reprint of the original 1st ed. 1998
Editura: SPRINGER VIENNA
Colecția Springer
Seria Journal of Neural Transmission. Supplementa
Locul publicării:Vienna, Austria
Public țintă
ResearchCuprins
Anti-oxidants and cognitive function: a review of clinical and epidemiologic studies.- Brain abnormalities in the elderly: frequency and predictors in the United States (the Cardiovascular Health Study).- Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam study.- The spectrum of age-associated brain abnormalities: their measurement and histopathological correlates.- Cognitive correlates of cerebral white matter changes.- Concepts on the prognostic significance of white matter changes.- Difficulties in the clinical diagnosis of vascular dementia and dementia of the Alzheimer type — comparison of clinical classifications.- Problems of differential diagnosis between depressive pseudo- dementia and Alzheimer’s disease.- The neuropathological diagnosis of Alzheimer disease.- The progression of the lesions in Alzheimer disease: insights from a prospective clinico- pathological study.- Evolution of neuronal changes in the course of Alzheimer’s disease.- The cytoskeleton in Alzheimer disease.- Mechanisms of synaptic pathology in Alzheimer’s disease.- Proteolytic processing of Alzheimer’s disease associated proteins.- Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.- Presenilins and Alzheimer’s disease: the role of A?42.- Biological markers for the diagnosis of Alz- heimer’s disease.- Apolipoprotein E4, cholinergic integrity and the pharmaco- genetics of Alzheimer’s disease.- Cerebrospinal fluid levels of A?42 and tau: potential markers of Alzheimer’s disease.- Combination of the different biological markers for increasing specificity of in vivo Alzheimer’s testing.- Positron emission tomography for diagnosis of Alzheimer’s disease and vascular dementia.- Current diagnostic methods andoutcome variables for clinical investigation of Alzheimer’s disease.- Perspectives in clinical Alzheimer’s disease research and the development of antidementia drugs.- The role of glutamate in dementia.- Neurotrophic activities and therapeutic experience with a brain-derived peptide preparation.- Brain-derived peptides reduce the size of cerebral infarction and loss of MAP2 immunoreactivity after focal ischemia in rats.- The influence of Cerebrolysin® and E021 on spatial navigation of 24-month-old rats.- Molecular regulation of the blood-brain barrier GLUT1 glucose transporter by brain-derived factors.- Antioxidant systemic effect of short-term Cerebrolysin® administration.- Can Cerebrolysin® influence chronic deterioration of spatial learning and memory?.- Cerebrolysin® protects isolated cortical neurons from neurodegeneration after brief histotoxic hypoxia.- Further evidence that Cerebrolysin® protects cortical neurons from neurodegeneration in vitro.- Influence of BDNF and FCS on viability and programmed cell death (PCD) of developing cortical chicken neurons in vitro.- Dose-dependent effects of Cerebrolysin® on EEG and short term memory of healthy volunteers during control and hyperventilation induced cerebral ischemia.